Dr. Janet Pope
Dr. Janet Pope, MD MPH FRCPC, is a Professor of Medicine and Division Head in the Division of Rheumatology at the University of Western Ontario (UWO), Schulich School of Medicine, London, Ontario, Canada. Her research includes studies in scleroderma, SLE and RA. She has published over 500 peer-reviewed articles and mentored more than 125 trainees. She has received the Distinguished Investigator Award from the Canadian Rheumatology Association, Rheumatologist of the Year from the Ontario Rheumatology Association, Department of Medicine Research Achievement Award, and the Dean’s Award of Excellence in Research. She has been inducted into the Canadian Academy of Health Sciences.
Sabrina Hoa, MD MSc FRCPC, is a rheumatologist at the Centre Hospitalier de l’Université de Montréal (CHUM), assistant professor in the Department of Medicine at the University of Montreal and clinician-researcher at the CHUM Research Centre. Dr. Hoa completed a post-doctoral fellowship in systemic sclerosis and a Masters in Epidemiology at McGill University. The topic of her thesis was on the role of immunosuppressive drugs in the treatment of mild interstitial lung disease associated with systemic sclerosis, as well as on the role of these treatments in the prevention of lung disease. Her training was funded by a Master’s award from the Canadian Institutes for Health Research (CIHR) and by a post-doctoral award from The Arthritis Society. Her research was selected by the Arthritis Society as being part of the Top 10 Research Advances in 2019.
Dr. Robinson is an associate Professor in the Department of Medicine at the University of Manitoba, and works at the Rheumatology Department at Health Sciences Centre. Dr. Robinson is Scleroderma Manitoba’s key medical advisor.Dr. Robinson completed his BSc at the University of Winnipeg, and his MSc in Physiology at the University of Manitoba. He then completed medical school, internal medicine training and rheumatology training at the University of Manitoba. He now works in the Rheumatology department at the University of Manitoba.
As a clinician educator David has a large tertiary care practice, treating approximately 1400 patients, of which about 70 are Scleroderma patients. David is a member of the Canadian Scleroderma Research Group, and has contributed to over 70 research citations including scientific papers, conference proceedings and a book chapter. Among other projects, he is currently involved in a clinical trial on cannabinols in Scleroderma, as well as working collaboratively on the potential for Stem Cell treatments in Manitoba.
Dr. Man completed her Internal Medicine residency at the University of Toronto. She then undertook her Rheumatology residency at the University of British Columbia, and was the recipient of Gurmej Kaur Dhanda Scholarship awards for Systemic Sclerosis in 2011 & 2012. She spent two years in Boston, USA at the Boston University Scleroderma Research Center for a research fellowship with an emphasis on epidemiology research as applied to Systemic Sclerosis. Her research was focused on cardiovascular outcomes, interstitial lung disease progression, as well as patient reported outcome measures in Systemic Sclerosis. She and her team developed the SSPRO – Scleroderma Skin Patient Reported Outcome – which has been validated in Systemic Sclerosis patients, and will be used in clinical trials. She practices General Rheumatology with a special interest in Systemic Sclerosis at the Manitoba Clinic in Winnipeg, and is an Assistant Professor of Medicine and Community Health Sciences, Rady Faculty of Health Sciences, University of Manitoba. She is a member of the Canadian working group for stem cell transplant in Systemic Sclerosis.